Protalix BioTherapeutics, Inc. - COM (PLX)

Q1 2022 13F Holders as of 3/31/2022

Type / Class
Equity / COM
Number of holders
28
Total Shares
1.22M
Shares change
-1.69M
Total reported value, excl. options
$1.29M
Value change
-$1.77M
Put/Call ratio
0.25
Number of buys
12
Number of sells
-12
Price
$1.06
Investor Option Weight % Change % Value $ * Price $ Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.